The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Amgen; AstraZeneca; Blueprint Medicines; Novartis; Roche/Genentech
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Bayer (Inst); Blueprint Medicines (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); GlaxoSmithKline (Inst); Innate Pharma (Inst); Janssen (Inst); Lilly (Inst); Loxo (Inst); Merck Serono (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Plexxikon (Inst); Roche/Genentech (Inst); Taiho Pharmaceutical (Inst); Toray Industries (Inst); Transgene (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Merck Sharp & Dohme; Netris Pharma; Novartis; Roche
LEAP-005: A phase 2 multicohort study of lenvatinib plus pembrolizumab in patients with previously treated selected solid tumors—Results from the gastric cancer cohort.
 
Hyun Cheol Cheol Chung
Consulting or Advisory Role - Amgen; Beigene; Bristol-Myers Squibb; Celltrion; Gloria Biosciences; Lilly; Merck Serono; MSD; Quintiles; Taiho Pharmaceutical; Zymeworks
Speakers' Bureau - Foundation medicine; Lilly; Merck Serono
Research Funding - Amgen (Inst); Beigene (Inst); Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Lilly (Inst); Merck Serono (Inst); MSD (Inst); Taiho Pharmaceutical (Inst); Zymeworks (Inst)
 
Zarnie Lwin
Honoraria - AstraZeneca
Consulting or Advisory Role - Abbvie; AstraZeneca; Merck; Roche
Speakers' Bureau - AstraZeneca
Research Funding - Abbvie; Bristol-Myers Squibb
Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim; Bristol Myer Squibb
 
Carlos A. Gomez-Roca
Honoraria - Bristol-Myers Squibb; Eisai; Foundation Medicine; Genentech/Roche; Pierre Fabre
Consulting or Advisory Role - Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb (Inst); Roche/Genentech
Travel, Accommodations, Expenses - Pierre Fabre; Roche
 
Federico Longo
Honoraria - Amgen; Bayer; Bristol-Myers Squibb; Celgene; Ferrer; Lilly; Merck; MSD; Roche; Sanofi; SERVIER
Consulting or Advisory Role - Amgen; Bayer; Bristol-Myers Squibb; Lilly; MSD; Roche; SERVIER
Travel, Accommodations, Expenses - Amgen; Bayer; Bristol-Myers Squibb; Celgene; Ferrer; Lilly; Merck; MSD; Roche; Sanofi; SERVIER
 
Eduardo Yanez
Honoraria - Abbott Laboratories
Consulting or Advisory Role - Abbott Laboratories; Bristol-Myers Squibb; Merck Serono
Research Funding - Abbvie (Inst); Bristol-Myers Squibb (Inst); MSD (Inst); Pfizer (Inst); Roche (Inst)
Expert Testimony - Abbott Laboratories
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Eduardo Castanon Alvarez
Honoraria - Bms spain; Roche
Consulting or Advisory Role - BeiGene
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; Bms Spain; MSD; Roche; Roche
 
Donna M. Graham
Honoraria - McCann Health
Consulting or Advisory Role - Clinigen Group
Research Funding - 3-V Biosciences (Inst); Actuate Therapeutics (Inst); Adaptimmune (Inst); Adaptimmune (Inst); AstraZeneca (Inst); Athenex (Inst); Bayer (Inst); BerGenBio (Inst); Blueprint Medicines (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Carrick Therapeutics (Inst); CytomX Therapeutics (Inst); Debiopharm Group (Inst); Eisai (Inst); Genmab (Inst); GlaxoSmithKline (Inst); Ignyta (Inst); Incyte (Inst); Janssen (Inst); Macrogenics (Inst); MedImmune (Inst); Merck Sharp & Dohme (Inst); Millenium Pharamceuticals (Inst); Novartis (Inst); Octimet (Inst); Orion (Inst); Pfizer (Inst); Redx Pharma (Inst); Redx Pharma (Inst); Roche (Inst); Sierra Oncology (Inst); Synthon (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst)
 
Mark Doherty
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Eisai; Merck; Pfizer; Roche; Takeda
Research Funding - AstraZeneca; Merck
 
Philippe Cassier
No Relationships to Disclose
 
Juanita Suzanne Lopez
Consulting or Advisory Role - Basilea; Genmab; Novartis
Research Funding - Basilea (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Basilea; Roche/Genentech
 
Bristi Basu
Consulting or Advisory Role - Eisai (Inst); GenMab (Inst); Roche (Inst)
Speakers' Bureau - Eisai Europe; Eisai Europe (Inst)
Research Funding - Celgene (Inst)
Travel, Accommodations, Expenses - Roche
 
Andrew Eugene Hendifar
Consulting or Advisory Role - Abbvie; Celgene; Eisai; Ipsen; Novartis; Perthera
Research Funding - Ipsen
Travel, Accommodations, Expenses - Halozyme
 
Corinne Maurice-Dror
Honoraria - Bristol Myers Squibb Foundation; Medison; MSD
Travel, Accommodations, Expenses - Janssen
 
Sanjeev Singh Gill
No Relationships to Disclose
 
Razi Ghori
Employment - Merck
 
Peter Kubiak
Employment - Eisai
 
Fan Jin
Employment - Merck
Stock and Other Ownership Interests - Merck
Travel, Accommodations, Expenses - Merck; Merck
 
Kevin Glen Norwood
Employment - Merck Sharp & Dohme
Stock and Other Ownership Interests - Merck
 
Esma Saada-Bouzid
No Relationships to Disclose